Sabra Healthcare Reit Stock Revenue
| SBRA Stock | USD 14.35 0.13 0.91% |
Sabra Healthcare REIT fundamentals help investors to digest information that contributes to Sabra Healthcare's financial success or failures. It also enables traders to predict the movement of Sabra Stock. The fundamental analysis module provides a way to measure Sabra Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sabra Healthcare stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 655.8 M | 404.9 M |
Sabra | Revenue |
Sabra Healthcare REIT Company Revenue Analysis
Sabra Healthcare's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Sabra Healthcare Revenue | 655.85 M |
Most of Sabra Healthcare's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Healthcare REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Sabra
Projected quarterly revenue analysis of Sabra Healthcare REIT provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Sabra Healthcare match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Sabra Healthcare's stock price.
Sabra Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Sabra Healthcare is extremely important. It helps to project a fair market value of Sabra Stock properly, considering its historical fundamentals such as Revenue. Since Sabra Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sabra Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sabra Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Sabra Revenue Historical Pattern
Today, most investors in Sabra Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sabra Healthcare's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sabra Healthcare revenue as a starting point in their analysis.
Sabra Healthcare Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Sabra Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Sabra Healthcare REIT reported 655.85 M of revenue. This is 56.75% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The revenue for all United States stocks is 93.05% higher than that of the company.
Sabra Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sabra Healthcare's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sabra Healthcare could also be used in its relative valuation, which is a method of valuing Sabra Healthcare by comparing valuation metrics of similar companies.Sabra Healthcare is currently under evaluation in revenue category among related companies.
Sabra Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Sabra Healthcare from analyzing Sabra Healthcare's financial statements. These drivers represent accounts that assess Sabra Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sabra Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 4.0B | 3.6B | 3.0B | 2.9B | 3.3B | 3.5B | |
| Enterprise Value | 6.4B | 5.9B | 5.2B | 5.5B | 5.7B | 3.2B |
Sabra Healthcare Institutional Holders
Institutional Holdings refers to the ownership stake in Sabra Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sabra Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sabra Healthcare's value.| Shares | Deutsche Bank Ag | 2023-12-31 | 3.6 M | Dimensional Fund Advisors, Inc. | 2023-12-31 | 3.2 M | Bank Of America Corp | 2023-12-31 | 2.8 M | Goldman Sachs Group Inc | 2023-12-31 | 2.3 M | Norges Bank | 2023-12-31 | 2.2 M | Nuveen Asset Management, Llc | 2023-12-31 | 2.2 M | Duff & Phelps Inv Mgmt Co (il) | 2023-12-31 | 2.1 M | Systematic Financial Management Lp | 2023-12-31 | 2 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2 M | Blackrock Inc | 2023-12-31 | 34.5 M | Vanguard Group Inc | 2023-12-31 | 34.1 M |
Sabra Fundamentals
| Return On Equity | 0.0047 | ||||
| Return On Asset | 0.0245 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 5.69 B | ||||
| Shares Outstanding | 231.5 M | ||||
| Shares Owned By Insiders | 1.14 % | ||||
| Shares Owned By Institutions | 94.40 % | ||||
| Number Of Shares Shorted | 11.34 M | ||||
| Price To Earning | 67.37 X | ||||
| Price To Book | 1.14 X | ||||
| Price To Sales | 4.94 X | ||||
| Revenue | 655.85 M | ||||
| Gross Profit | 372.8 M | ||||
| EBITDA | 418.15 M | ||||
| Net Income | 13.76 M | ||||
| Cash And Equivalents | 49.05 M | ||||
| Cash Per Share | 0.21 X | ||||
| Total Debt | 2.45 B | ||||
| Debt To Equity | 0.76 % | ||||
| Current Ratio | 0.78 X | ||||
| Book Value Per Share | 12.12 X | ||||
| Cash Flow From Operations | 301.12 M | ||||
| Short Ratio | 6.20 X | ||||
| Earnings Per Share | 0.06 X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 15.91 | ||||
| Number Of Employees | 48 | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 3.32 B | ||||
| Total Asset | 5.39 B | ||||
| Retained Earnings | (1.72 B) | ||||
| Working Capital | 311.89 M | ||||
| Current Asset | 17.25 M | ||||
| Current Liabilities | 35.18 M | ||||
| Annual Yield | 0.08 % | ||||
| Five Year Return | 9.02 % | ||||
| Net Asset | 5.39 B | ||||
| Last Dividend Paid | 1.2 |
About Sabra Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sabra Healthcare REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sabra Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sabra Healthcare REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Sabra Healthcare Investors Sentiment
The influence of Sabra Healthcare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Sabra. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Sabra Healthcare's public news can be used to forecast risks associated with an investment in Sabra. The trend in average sentiment can be used to explain how an investor holding Sabra can time the market purely based on public headlines and social activities around Sabra Healthcare REIT. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sabra Healthcare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sabra Healthcare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Sabra Healthcare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Sabra Healthcare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sabra Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sabra Healthcare's short interest history, or implied volatility extrapolated from Sabra Healthcare options trading.
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out Sabra Healthcare Piotroski F Score and Sabra Healthcare Altman Z Score analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Sabra Stock analysis
When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Sabra Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.286 | Dividend Share 1.2 | Earnings Share 0.06 | Revenue Per Share 2.788 | Quarterly Revenue Growth 0.933 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.